ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,830Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 231

$725K Total Retail Price of All Prescriptions

Rank: 10 out of 231

531 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 531 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 531 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 9,150 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $74 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
LISINOPRIL 383 293 1 1
SIMVASTATIN 377 277 2 2
OMEPRAZOLE 359 233 3 5
LEVOTHYROXINE SODIUM 353 270 4 3
FUROSEMIDE 279 211 5 6
AMLODIPINE BESYLATE 248 205 6 4
CITALOPRAM HBR 225 155 7 20
ZOLPIDEM TARTRATE 219 164 8 14
ATORVASTATIN CALCIUM 206 180 9 8
INSULIN SYRINGE 204 193 10 43
WARFARIN SODIUM 176 176 11 17
PRAVASTATIN SODIUM 175 141 12 10
METOPROLOL TARTRATE 174 122 13 12
OXYCODONE HCL 172 113 S2 14 23
HYDROCHLOROTHIAZIDE 171 140 15 9
METOPROLOL SUCCINATE 169 157 16 13
METFORMIN HCL 157 85 17 7
ATENOLOL 154 140 18 11
GABAPENTIN 153 93 19 15
GLIMEPIRIDE 147 129 20 38
DIOVAN 141 121 21 27
HYDROCODONE-ACETAMINOPHEN 137 115 S3 22 21
QUETIAPINE FUMARATE 121 117 23 39
TRAMADOL HCL 117 95 24 16
ISOSORBIDE MONONITRATE ER 117 114 24 56
DIOVAN HCT 113 107 26 84
MECLIZINE HCL 110 90 27 149
CLOPIDOGREL 107 88 28 44
LANTUS 104 94 29 42
TAMSULOSIN HCL 98 94 30 30
ESCITALOPRAM OXALATE 95 85 31 55
CARVEDILOL 94 69 32 24
CYCLOBENZAPRINE HCL 94 70 R 32 86
LANSOPRAZOLE 91 52 34 152
PAROXETINE HCL 88 57 35 70
ALLOPURINOL 87 59 36 48
SERTRALINE HCL 85 61 37 18
FLUOXETINE HCL 84 44 38 67
POTASSIUM CHLORIDE 83 79 39 33
ADVAIR DISKUS 76 31 40 50
CLONIDINE HCL 75 43 41 63
CRESTOR 75 50 41 19
PREDNISONE 74 63 43 41
NEXIUM 73 54 44 31
AMOX TR-POTASSIUM CLAVULANATE 72 53 45 81
NOVOLOG 71 65 46 72
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 59 47 22
SYNTHROID 67 55 48 28
LOSARTAN POTASSIUM 67 62 48 29
CYMBALTA 64 30 50 46
RISPERIDONE 60 40 51 34
TRAZODONE HCL 60 40 51 35
AZITHROMYCIN 58 42 53 32
PLAVIX 56 51 54 60
PROAIR HFA 55 35 55 59
PANTOPRAZOLE SODIUM 54 49 56 62
BACLOFEN 53 26 57 89
ZETIA 52 49 58 125
CIPROFLOXACIN HCL 52 47 58 58
IBUPROFEN 51 33 60 96
BUPROPION XL 51 28 60 231
KETOCONAZOLE 50 34 62 138
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 27, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.